Hongos psilocibios como patrimonio biocultural y su potencial para el desarrollo local en la Sierra Mazateca de Oaxaca
Diego Hannon Ovies
Perspectiva geográfica June 18, 2021 DOI: 10.19053/01233769.12400 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Population | Mazateca community in the Sierra Mazateca of Oaxaca, Mexico |
| Citations | 1 |
| Key findings | The Mazateca community recognizes the potential of psilocybin mushrooms and favors their tourist use, but lacks cooperative capacities for regional conservation and development strategies. |
Abstract
Despite the fundamental role played by psilocybin mushrooms in traditional indigenous medicine in Mexico since time immemorial, their institutional neglect and their illegal status make it impossible to deploy conservation, research and exploitation schemes for this endogenous biocultural resource. Starting from the conceptual paradigm of bioculturality and from the socio-territorial approach of local development, this article presents a discussion on the potential of psilocybin mushrooms to become a biocultural heritage in Mexico and to favor local development in the Sierra Mazateca of Oaxaca. The article is methodologically based on a documentary and ethnographic research to highlight the biocultural value and therapeutic potential of psilocybin mushrooms in order to propose their institutional and scientific recognition at the national level. The results indicate that the Mazateca community recognizes the endogenous potential of psilocybin mushrooms and favors their tourist use. However, the absence of community capacities for cohesive cooperation inhibits the articulation of regional conservation and development strategies. The final reflection proposes that the dynamization of visionary plants through biocultural conservation schemes and responsible tourism use can contribute to poverty alleviation in indigenous regions.
Citations in the library
Cites 11
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology November 8, 2017
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Journal of Psychopharmacology September 11, 2014
- Reviewing the Potential of Psychedelics for the Treatment of PTSD The International Journal of Neuropsychopharmacology March 12, 2020
- The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis Psychiatry Research January 2, 2020
- Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations Psychopharmacology July 31, 2015
and 6 more in the library